Head-to-head · free

Akanda Corp. vs Amgen

AKAN vs AMGN — return on capital, cash generation, margins and balance sheet side by side.

AKAN

1 / 3

measures where AKAN leads

AMGN

2 / 3

measures where AMGN leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureAKANAMGN · FY2025
Revenue—$36.8B
Net income—$7.7B
Revenue growth (yearly, multi-year)—9.1%
Free cash flow—$8.1B
Free cash flow margin—22.0%
Net cash / (debt)——
ROIC—11.8%
Return on equity—106.1%
Gross margin-60.5%67.2%
Operating margin-1931.0%24.7%
Net debt / EBITDA-2.93x3.19x

Figures are as reported by each company; latest fiscal year shown.

Where Akanda Corp.'s cash went

Not reported yet.

Full AKAN profile →

Where Amgen's cash went (FY2025)

Capital spending
$1.9B
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full AMGN profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons